Hologic, Inc. (BMV:HOLX)
Mexico · Delayed Price · Currency is MXN 1,263.00
0.00 (0.00%)
At close: Jul 31, 2025
Revenue by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 28, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 24, 2022 | Sep '21 Sep 25, 2021 | Sep '20 Sep 26, 2020 | 2013 - 2019 |
Diagnostics | 1.78B | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics Growth | 3.49% | Log In | Log In | Log In | Log In | Upgrade |
Breast Health | 1.52B | Log In | Log In | Log In | Log In | Upgrade |
Breast Health Growth | -2.27% | Log In | Log In | Log In | Log In | Upgrade |
GYN Surgical | 641.30M | Log In | Log In | Log In | Log In | Upgrade |
GYN Surgical Growth | 4.88% | Log In | Log In | Log In | Log In | Upgrade |
Skeletal Health | 84.10M | Log In | Log In | Log In | Log In | Upgrade |
Skeletal Health Growth | -6.73% | Log In | Log In | Log In | Log In | Upgrade |
Other | 100.00K | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 100.00K | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 100.00K | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Capex by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 28, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 24, 2022 | Sep '21 Sep 25, 2021 | Sep '20 Sep 26, 2020 | 2013 - 2019 |
Other | 1.10M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics Capital Expenditures | 80.20M | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics Capital Expenditures Growth | 27.68% | Log In | Log In | Log In | Log In | Upgrade |
Breast Health Capital Expenditures | 30.90M | Log In | Log In | Log In | Log In | Upgrade |
Breast Health Capital Expenditures Growth | -66.35% | Log In | Log In | Log In | Log In | Upgrade |
GYN Surgical Capital Expenditures | 16.60M | Log In | Log In | Log In | Log In | Upgrade |
GYN Surgical Capital Expenditures Growth | 56.25% | Log In | Log In | Log In | Log In | Upgrade |
Skeletal Health Capital Expenditures | 1.40M | Log In | Log In | Log In | Log In | Upgrade |
Skeletal Health Capital Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.10M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.10M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 28, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 24, 2022 | Sep '21 Sep 25, 2021 | Sep '20 Sep 26, 2020 | 2013 - 2019 |
Other | 87.60M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 87.60M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics Operating Income | 303.10M | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics Operating Income Growth | 31.04% | Log In | Log In | Log In | Log In | Upgrade |
Breast Health Operating Income | 394.50M | Log In | Log In | Log In | Log In | Upgrade |
Breast Health Operating Income Growth | 7.57% | Log In | Log In | Log In | Log In | Upgrade |
GYN Surgical Operating Income | 185.50M | Log In | Log In | Log In | Log In | Upgrade |
GYN Surgical Operating Income Growth | -93.46% | Log In | Log In | Log In | Log In | Upgrade |
Skeletal Health Operating Income | -500.00K | Log In | Log In | Log In | Log In | Upgrade |
Skeletal Health Operating Income Growth | -270.21% | Log In | Log In | Log In | Log In | Upgrade |
Other | 87.60M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |